use
vaccin
main
approach
control
econom
import
poultri
viral
respiratori
diseas
infecti
laryngotrach
ilt
avian
metapneumoviru
ampv
infect
infecti
bronchiti
ib
paper
apprais
current
method
vaccin
control
light
natur
viru
epidemiolog
factor
associ
diseas
infecti
laryngotrach
viru
iltv
exist
singl
type
wide
rang
diseas
sever
seriou
diseas
certain
region
world
recent
work
distinguish
molecular
differ
vaccin
field
strain
vaccin
viru
caus
diseas
vaccin
remain
unalt
mani
year
new
one
develop
counter
vaccin
side
effect
revers
reactiv
latent
viru
avian
metapneumovirus
caus
turkey
rhinotrach
respiratori
diseas
chicken
exist
subtyp
b
c
b
widespread
vaccin
work
well
provid
accur
dose
given
newer
vaccin
develop
design
elimin
revers
possibl
counter
appear
newer
field
strain
may
break
establish
vaccin
coverag
ib
present
biggest
problem
three
unstabl
rna
viru
part
viral
genom
code
spike
gene
undergo
mutat
recombin
import
antigen
variant
appear
irregularli
may
evad
exist
vaccin
protect
convent
vaccin
work
well
homolog
type
new
strategi
need
counter
instabl
molecular
approach
involv
tailor
virus
suit
field
challeng
progress
howev
simpl
use
two
genet
differ
vaccin
protect
wide
rang
heterolog
type
widespread
practic
effect
none
three
diseas
describ
claim
satisfactorili
control
remain
seen
whether
newer
gener
vaccin
efficaci
cost
effect
import
constant
surveil
emphasis
test
novel
vaccin
achiev
without
use
vaccinechalleng
experi
poultri
viral
respiratori
diseas
poultri
constitut
import
caus
econom
loss
poultri
industri
worldwid
term
impair
growth
reduc
egg
product
qualiti
mortal
slaughter
downgrad
sever
ancillari
factor
includ
diagnos
vaccin
antimicrobi
treat
intercurr
bacteri
infect
etc
diseas
potenti
caus
sever
loss
term
mortal
virul
newcastl
diseas
highli
pathogen
avian
influenza
three
viral
respiratori
diseas
constitut
might
call
second
tier
import
term
diseas
sever
name
infecti
laryngotrach
ilt
avian
metapneumoviru
ampv
infect
caus
infect
turkey
rhinotrach
avian
rhinotrach
infecti
bronchiti
ib
ib
econom
import
uk
alon
report
respons
loss
amount
million
annual
three
diseas
sever
exacerb
prolong
concurr
infect
bacteria
includ
e
coli
mycoplasma
gallisepticum
bird
immunosuppress
infecti
bursal
diseas
chicken
anaemia
viru
infect
howev
paper
concentr
uncompl
infect
alon
three
live
vaccin
avail
wide
use
control
variabl
paper
attempt
assess
success
control
vaccin
take
account
natur
virus
differ
epidemiolog
featur
influenti
respect
three
virus
unrel
belong
differ
group
viru
classif
infecti
laryngotrach
viru
iltv
alphaherp
viru
assign
iltoviru
genu
figur
ilt
one
earliest
diseas
describ
poultri
affect
chicken
pheasant
rare
turkey
avian
metapneumoviru
ampv
figur
belong
paramyxovirida
famili
caus
turkey
rhinotrach
origin
report
south
africa
late
affect
chicken
also
youngest
three
ib
caus
type
coronaviru
figur
first
report
still
flourish
despit
year
attempt
control
diseas
caus
virus
use
vaccin
still
present
ilt
occur
chicken
wide
spectrum
diseas
sever
rang
subclin
peracut
signific
mortal
guy
garcia
unlik
ib
ampv
infect
ilt
appear
sole
affect
respiratori
tract
spread
rapidli
diseas
sometim
sever
occur
certain
region
world
usual
remain
endem
countri
unknown
littl
import
iltv
exist
singl
serotyp
advantag
point
view
control
vaccin
also
help
serolog
diagnosi
differ
strain
eg
wild
vaccin
virus
differenti
molecular
method
one
aspect
ilt
epidemiolog
relat
herp
viru
becom
latent
within
chicken
guy
garcia
essenti
mean
affect
bird
recov
acut
phase
infect
viru
assum
noninfecti
state
resid
trigemin
ganglia
william
et
al
though
flock
appear
normal
health
live
ilt
vaccin
also
becom
latent
hugh
et
al
consequ
latent
viru
becom
reactiv
factor
stress
onset
lay
hugh
et
al
flock
becom
unrecognis
sourc
infect
william
et
al
known
wild
bird
reservoir
viru
evid
egg
transmit
bagust
johnson
control
use
live
vaccin
endem
area
flock
owner
afraid
stop
vaccin
initi
studi
hint
promot
natur
latenc
ilt
vaccin
respons
outbreak
diseas
naiv
flock
improv
molecular
techniqu
confirm
happen
field
strain
viru
unrel
vaccin
strain
ojkic
et
al
oldoni
et
al
neff
et
al
recent
molecular
investig
shown
differ
strain
ilt
virus
differ
region
worth
point
molecular
group
given
differ
label
accord
genet
comparison
tabl
europ
studi
strain
collect
year
show
strain
relat
vaccin
neff
et
al
similar
studi
usa
oldoni
et
al
found
genotyp
report
relat
vaccin
strain
australia
genet
group
establish
contrast
ilt
consid
due
vaccin
type
kirkpatrick
et
al
new
strain
report
appear
recent
australia
ilt
consid
emerg
diseas
one
know
origin
empir
attenu
ilt
vaccin
either
chick
embryo
origin
ceo
tissu
cultur
origin
tco
use
mani
year
success
guy
garcia
time
ago
discov
commerci
vaccin
use
uk
behav
way
field
viru
latenc
characterist
wild
type
iltv
bird
persist
life
hugh
et
al
thu
perceiv
signific
proport
diseas
could
due
vaccin
viru
becom
wild
recent
refer
usa
vaccin
laryngotrach
molecular
analysi
shown
confirm
case
howev
korean
worker
found
one
four
convent
ilt
vaccin
protect
viru
latenc
han
kim
despit
presenc
iltv
strain
genet
differ
vaccin
strain
problem
associ
convent
ilt
vaccin
includ
vaccin
reaction
especi
respiratori
agent
present
revers
vaccin
virus
virul
latenc
later
reactiv
addit
ilt
vaccin
usual
given
week
age
later
bird
vulner
point
result
sever
new
approach
explor
produc
new
gener
safer
vaccin
includ
product
glycoprotein
gdefici
vaccin
devlin
et
al
g
associ
latenc
fowl
pox
vector
carri
iltv
gene
davison
et
al
glycoprotein
g
togeth
haemagglutinin
newcastl
diseas
viru
sun
et
al
remain
seen
whether
vaccin
type
prove
efficaci
empir
deriv
vaccin
new
vaccin
recent
triall
usa
south
america
consist
marek
diseas
turkey
herpesviru
thv
vaccin
use
vector
contain
iltv
gene
gd
gi
tarpey
person
commun
vaccin
given
inject
onedayold
sinc
thv
vaccin
persist
chicken
claim
give
lifelong
immun
ilt
contain
defin
ilt
gene
problem
respiratori
reaction
latenc
final
worth
note
bagust
johnson
suggest
iltv
could
suitabl
candid
erad
sinc
number
properti
appropri
approach
control
includ
exist
singl
serotyp
lack
vertic
transmiss
appar
wildlif
reservoir
propos
use
genet
defin
marker
vaccin
mention
togeth
match
elisa
latter
would
distinguish
vaccin
respons
field
infect
permit
differenti
bird
natur
infect
given
vaccin
iltv
virus
stay
remark
stabl
year
compar
say
ibv
distinguish
molecular
method
ilt
continu
caus
diseas
problem
especi
america
australia
year
vaccin
deriv
egg
tissu
cultur
passag
remain
mostli
unalt
problem
vaccin
reaction
revers
vaccin
viru
virul
latenc
new
genotyp
differ
vaccin
emerg
particularli
australia
usa
convent
vaccin
shown
effect
genet
variant
et
al
futur
variant
emerg
evad
vaccin
protect
anoth
question
sinc
known
wildlif
reservoir
recognis
variant
origin
date
ilt
may
consid
restrain
rather
well
control
perhap
new
vaccin
turkey
herp
vector
vaccin
allow
much
better
control
avian
metapneumoviru
caus
turkey
rhinotrach
trt
first
seen
south
africa
buy
et
al
soon
shown
caus
respiratori
diseas
chicken
avian
rhinotrach
art
sometim
swollen
head
syndrom
sh
gough
jone
ampv
soon
spread
europ
middl
east
part
world
commerci
poultri
kept
apart
australia
north
america
initi
two
subtyp
viru
recognis
b
base
differ
surfac
glycoprotein
gene
sequenc
juhasz
easton
third
subtyp
c
identifi
usa
turkey
colorado
later
import
turkey
produc
state
minnesota
seal
usa
diseas
call
avian
pneumoviru
infect
turkey
subtyp
c
appear
import
chicken
subsequ
subtyp
describ
franc
et
al
variant
c
appear
duck
countri
toquin
et
al
surprisingli
subtyp
c
report
south
korea
pheasant
market
lee
et
al
ampv
primarili
affect
respiratori
tract
especi
upper
tissu
figur
abl
replic
oviduct
latter
result
loss
egg
product
qualiti
gough
jone
sinc
first
report
ampv
south
africa
subsequ
appear
part
world
mode
spread
virus
sourc
conjectur
viru
reach
europ
middl
east
afield
south
africa
unknown
one
suggest
transmiss
longdist
migratori
bird
jone
although
effort
find
evid
infect
wild
european
speci
fruit
perhap
even
puzzl
fact
subtyp
c
present
turkey
usa
princip
minnesota
mani
lake
b
present
central
south
america
appar
mix
subtyp
two
region
despit
migratori
flight
path
wild
waterfowl
north
south
evid
ampv
infect
wild
bird
report
usa
shin
et
al
turpin
et
al
mean
infect
speci
abl
transmit
infect
suscept
poultri
isol
ampv
young
turkey
gough
et
al
presenc
abund
amount
viru
oviduct
infect
lay
turkey
jone
et
al
suggest
egg
transmiss
may
occur
time
time
main
approach
control
ampv
infect
use
live
attenu
kill
vaccin
former
deriv
attenu
cell
cultur
fertil
egg
tracheal
organ
cultur
cook
elli
william
et
al
chicken
live
vaccin
incorpor
vaccin
programm
differ
time
ib
vaccin
sinc
interfer
occur
cook
et
al
although
ampv
vaccin
simultan
newcastl
diseas
vaccin
advers
affect
efficaci
either
ganapathi
et
al
kill
vaccin
given
inject
onset
lay
prime
live
vaccin
except
usa
subtyp
c
present
b
preval
subtyp
elsewher
vaccin
two
give
good
protect
cook
et
al
b
type
vaccin
also
give
protect
subtyp
c
vice
versa
cook
et
al
recent
survey
ampv
chicken
turkey
flock
western
europ
show
subtyp
b
predomin
countri
studi
perhap
reflect
wider
use
subtyp
b
vaccin
rc
jone
kj
worthington
unpublish
survey
distinguish
vaccin
field
virus
subtyp
b
vaccin
use
success
countri
speci
diseas
preval
spite
sever
report
suggest
room
improv
vaccin
least
closer
attent
accur
vaccin
deliveri
exampl
turkey
week
ampv
vaccin
respiratori
diseas
sometim
occur
diagnos
trt
phenomenon
confirm
due
vaccin
viru
becom
virul
recycl
among
bird
receiv
dose
vaccin
origin
catelli
et
al
recent
isra
longitudin
studi
ampv
infect
small
number
chicken
turkey
flock
reveal
vaccin
field
strain
ampv
b
subtyp
could
recov
simultan
banetnoach
et
al
recent
brazil
itali
cecchinato
et
al
field
evid
suggest
exist
vaccin
fulli
effect
new
strain
viru
though
empir
vaccin
effect
given
accur
move
made
formul
novel
vaccin
revert
virul
includ
vector
vaccin
subunit
vaccin
dna
vaccin
partial
effect
one
approach
involv
use
revers
genet
make
infecti
clone
look
promis
naylor
et
al
ling
et
al
cj
naylor
p
brown
person
commun
ovo
vaccin
shown
practic
effect
form
deliveri
protect
turkey
chicken
ampv
infect
worthington
et
al
tarpey
huggin
final
region
flock
densiti
low
appar
ampv
infect
erad
care
monitor
strict
attent
biosecur
exampl
sweden
colorado
subtyp
c
first
report
usa
howev
state
minnesota
c
gain
strong
foothold
immens
turkey
industri
diseas
erad
k
nagaraja
person
commun
serolog
monitor
shown
evid
ampv
time
turkey
industri
stop
vaccin
clinic
case
isol
made
year
small
number
subtyp
exist
b
c
rare
c
appear
import
usa
perhap
less
less
b
widespread
import
one
current
vaccin
success
administ
accur
bird
problem
aris
revers
evid
possibl
viru
evolut
new
safer
vaccin
develop
howev
work
banetnoach
et
al
israel
indic
wild
type
viru
still
present
vaccin
flock
illustr
control
less
satisfactori
present
vaccin
infecti
bronchiti
import
viral
respiratori
diseas
discuss
consid
import
endem
viral
diseas
poultri
countri
highli
pathogen
avian
influenza
virul
newcastl
diseas
present
cavanagh
gelb
diseas
chicken
turkey
addit
respiratori
diseas
affect
age
affect
growth
one
import
caus
loss
egg
product
qualiti
cavanagh
gelb
strain
predilect
kidney
caus
signific
mortal
young
bird
dhinakar
raj
jone
evid
ibv
may
sometim
associ
enter
infertil
male
villarr
et
al
b
control
ib
use
live
attenu
kill
vaccin
howev
ib
present
uniqu
challeng
regard
control
genom
divers
abil
viru
rapidli
chang
creat
differ
genotyp
viru
evad
protect
convent
vaccin
cavanagh
gelb
approach
counteract
problem
discuss
caus
ib
type
coronaviru
viru
infecti
bronchiti
viru
ibv
envelop
rna
viru
surfac
fring
clubshap
spike
spike
two
part
gene
code
spike
hypervari
region
liabl
mutat
undergo
reassort
ibv
thu
gener
novel
variant
ibv
spike
import
viral
attach
major
compon
develop
immun
tradit
import
crossneutralis
origin
basi
ibv
classif
differ
type
ibv
gener
give
littl
protect
heterolog
type
although
except
import
variant
appear
time
time
unpredict
manner
constant
challeng
vaccin
strategi
henc
constant
need
surveil
preval
type
recent
survey
ibv
commerci
chicken
flock
uk
franc
spain
holland
germani
belgium
worthington
et
al
posit
ibv
preval
genotyp
massachusett
major
variant
figur
basi
nucleotid
sequenc
share
ident
approxim
consid
vaccin
viru
etc
next
common
genotyp
two
new
import
field
type
itali
viru
origin
detect
china
call
qx
worthington
et
al
origin
itali
unknown
dolz
et
al
qx
origin
china
wang
et
al
though
arriv
europ
unknown
itali
behav
primarili
respiratori
pathogen
qx
seriou
consequ
caus
nephriti
young
flock
fals
layer
egg
lay
flock
survey
exampl
divers
ibv
genotyp
region
appear
new
one
consider
divers
well
document
usa
australia
china
recent
year
report
novel
genotyp
publish
brazil
argentina
rimondi
et
al
thailand
pohuang
et
al
malaysia
zulperi
et
al
africa
ducatez
et
al
ib
virus
affect
chicken
turkey
like
ampv
although
turkey
pheasant
differ
coronavirus
ibv
gener
consid
egg
transmit
abund
viru
oviduct
hen
shortli
infect
jone
jordan
chick
would
like
hatch
viru
undoubtedli
biggest
problem
control
relat
divers
type
appear
new
one
time
time
although
europ
number
import
variant
appear
last
year
rel
small
dutch
type
two
decad
itali
qxtheir
emerg
unpredict
perhap
increas
poultri
popul
greater
use
vaccin
promot
rapid
gener
new
type
wellestablish
genotyp
found
worldwid
eg
massachusett
part
due
widespread
use
vaccin
howev
larg
ignor
ibv
move
around
world
exampl
qx
origin
china
establish
europ
travel
across
asia
similar
time
span
taken
avian
influenza
far
know
without
mediat
wild
bird
increas
evid
wild
bird
infect
coronavirus
jonassen
et
al
woo
et
al
except
liu
et
al
sun
et
al
hugh
et
al
seem
unrel
ibv
yet
hard
evid
ibv
transmit
long
distanc
wild
speci
longterm
persist
ibv
demonstr
earli
infect
signific
unknown
jone
ambali
dhinakar
raj
jone
region
licens
vaccin
genotyp
field
challeng
ib
vaccin
work
well
howev
variant
appear
persist
exist
vaccin
protect
present
big
problem
number
possibl
exist
address
problem
new
import
variant
new
vaccin
perceiv
necessari
test
exist
repertoir
vaccin
sometim
protect
offer
unrel
vaccin
exampl
vaccin
protect
variant
figur
develop
empir
vaccin
attenu
egg
perhap
cell
cultur
tradit
fire
brigad
method
long
tediou
process
use
molecular
techniqu
engin
vaccin
new
challeng
viru
revert
virul
recent
exampl
modifi
dna
vaccin
tian
et
al
tan
et
al
multiepitopebas
peptid
vaccin
one
promis
new
gener
vaccin
appear
spike
swap
technolog
wherebi
use
revers
genet
infecti
clone
produc
specif
spike
gene
incorpor
appropri
new
variant
casai
et
al
variat
theme
also
includ
incorpor
nucleocapsid
gene
specif
cytokin
induc
broader
immun
cavanagh
et
al
use
two
heterolog
ibv
vaccin
cook
et
al
method
shown
success
even
though
mechan
elucid
date
usual
first
administ
massachusettstyp
vaccin
follow
variant
europ
offer
wide
protect
type
differ
figur
programm
jone
use
two
heterolog
vaccin
massachusett
give
good
protect
strain
ibv
unrel
either
protect
viru
either
vaccin
alon
poor
protect
assess
figur
cook
et
al
shown
efficaci
exampl
itali
qx
jone
et
al
figur
terregino
et
al
de
wit
van
de
sand
ovo
vaccin
develop
tarpey
et
al
depend
strain
ibv
kill
embryo
ib
highli
infecti
maintain
virusfre
flock
seem
impractic
main
choic
futur
strategi
ibv
control
seem
follow
product
specif
tailor
vaccin
produc
molecular
technolog
design
protect
variant
challeng
viru
advantag
viru
carrier
establish
mechan
insert
appropri
spike
gene
perhap
accessori
gene
cytokin
etc
avail
howev
question
aris
mani
tailor
vaccin
bird
take
number
variant
challeng
becom
larg
ii
use
two
differ
vaccin
simpl
employ
guarante
succeed
everi
case
mechan
fulli
establish
howev
unless
panibv
vaccin
produc
unlik
signific
success
stopgap
approach
ibv
show
viral
evolut
action
like
remain
one
step
ahead
three
viral
respiratori
diseas
consid
present
differ
problem
control
vaccin
iltv
affect
chicken
turkey
exist
singl
serotyp
strain
show
differ
virul
genet
differ
demonstr
clear
import
vaccin
formul
vaccin
remain
rel
unchang
improv
one
need
avoid
vaccin
reaction
problem
long
immun
countri
new
strain
emerg
origin
unknown
four
subtyp
ampv
exist
b
virtual
worldwid
affect
chicken
turkey
exist
vaccin
effect
given
accur
field
evid
revers
perhap
viru
evolut
highlight
need
improv
safer
vaccin
ib
present
biggest
challeng
errat
unpredict
appear
variant
may
evad
protect
exist
vaccin
like
solut
vaccin
control
may
tackl
specialis
typespecif
engin
vaccin
use
doubl
heterolog
vaccin
answer
longterm
ibv
variant
continu
aris
perhap
diseas
never
complet
control
difficulti
outlin
claim
three
diseas
satisfactorili
control
vaccin
ideal
scenario
produc
vaccin
new
diseas
mean
end
problem
appli
realiti
even
though
experiment
trial
sometim
produc
perfect
result
steril
vaccin
outcom
field
situat
quit
differ
three
virus
despit
widespread
use
live
vaccin
evid
mediat
refin
molecular
techniqu
wild
viru
circul
poor
vaccin
deliveri
overwhelm
field
challeng
intercurr
infect
viral
evolut
new
variant
outsid
immedi
region
conspir
milit
vaccin
efficaci
exist
vaccin
may
describ
restrain
rather
fulli
control
diseas
remain
seen
whether
new
gener
vaccin
satisfactori
exist
empir
one
cost
effect
think
expect
move
ovo
deliveri
conveni
even
though
yet
taken
wide
europ
final
thought
essenti
good
control
constant
surveil
use
optim
techniqu
avail
detect
virus
current
infect
poultri
popul
ad
benefit
alert
diagnostician
possibl
new
variant
current
virus
inde
new
diseas
agent
must
also
rememb
vaccin
efficaci
determin
use
vaccinechalleng
experi
bird
